10.01.2013 Views

SURGICAL PATHOLOGY OF ENDOCRINE AND ...

SURGICAL PATHOLOGY OF ENDOCRINE AND ...

SURGICAL PATHOLOGY OF ENDOCRINE AND ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

30 R.V. Lloyd et al.<br />

Anterior Pituitary Cell Hyperplasia<br />

Anterior pituitary cell hyperplasia is very uncommon [38,<br />

39]. Causes of anterior pituitary hyperplasia may be primary<br />

or idiopathic and secondary due to production of<br />

hypothalamic releasing hormones from tumors such as pulmonary<br />

or other neuroendocrine tumors producing GHRH,<br />

CRH, or other hypothalamic hormones. Other causes of<br />

secondary hyperplasia include end-organ failure such as<br />

thyroid or adrenal cortical atrophy leading to stimulation<br />

of TSH and ACTH cell proliferation, respectively, as part of<br />

the negative feedback mechanism. Secondary hyperplasia<br />

may also be related to hypothalamic hamartoma with production<br />

of hypothalamic hormones [9, 35]. Hyperplasia<br />

may be nodular or diffuse. Special stains such as reticulin<br />

and immunohistochemical stains for collagen 4 and/or<br />

pituitary hormones may help to establish the diagnosis of<br />

hyperplasia. Reticulin and collagen 4 stains show expansion<br />

of acinar unit. Immunohistochemical stains for specific<br />

hormones may show enlarged clusters of cells of a specific<br />

lineage in the expanded acini. The predominant cell type is<br />

often admixed with other types of cells in the acinar unit. It<br />

is important to appreciate the unique anatomical localization<br />

of specific cell types in the anterior pituitary in order to<br />

determine if the cells are increased. For example, ACTH<br />

cells are located predominately in the mucoid wedge, so<br />

the presence of abundant ACTH-positive cells in this<br />

region may not indicate hyperplasia. In addition, basophil<br />

invasion or the presence of abundant ACTH cells is<br />

the intermediate zone equivalent in a normal physiological<br />

change and does indicate ACTH cell hyperplasia.<br />

PRL cell hyperplasia is present during pregnancy,<br />

where the pituitary weight and number of PRL cells can<br />

be increased up to two fold. Primary cell hyperplasia is<br />

rare in human pituitaries. PRL cell hyperplasia has been<br />

reported in the non-neoplastic pituitary cells adjacent to<br />

PRL adenomas [38].<br />

ACTH cell hyperplasia may be nodular or diffuse.<br />

Nodular ACTH cell hyperplasia is characterized by an<br />

increase in the acinar size, hyperthyroidal ACTH cells,<br />

and expansion of the reticulin pattern. In contrast, diffuse<br />

ACTH cell hyperplasia is characterized by an increase in<br />

the number of ACTH cells, which may be more prominent<br />

in the mucoid wedge without significant distortion of<br />

the reticulin pattern. Patients with Addison’s disease and<br />

adrenal cortical atrophy may develop diffuse and/or<br />

nodular ACTH cell hyperplasia.<br />

GH cell hyperplasia may be striking under certain<br />

circumstances such as with GHRH producing tumors<br />

in the lungs or pancreas. Histologically, there is an<br />

expansion of the reticulin pattern with hypertrophic GH<br />

producing cells. Bi-hormonal cells producing GH and<br />

PRL may be present. Ultrastructural studies usually<br />

show cells with large dense core secretory glands, welldeveloped<br />

rough endoplasmic reticulin and prominent<br />

Golgi-complexes.<br />

Hyperplasia of TSH cells may be nodular and/or<br />

diffuse. Patients with chronic hypothyroidism with<br />

atrophy of the thyroid can develop TSH cell hyperplasia<br />

with expanded acinar units and weakly staining TSHpositive<br />

cells.<br />

Hyperplasia of gonadotrophic cells is uncommon. It<br />

may be associated with primary gonadal atrophy in a<br />

patient with Klinefelter and/or Turner syndrome [9, 35].<br />

Pituitary Adenomas<br />

GH-Producing Adenomas<br />

Most GH-producing adenomas are manifested clinically<br />

as gigantism, if the tumor develops before the epiphyseal<br />

plates have closed. This is usually characterized by<br />

excessive linear growth. Acromegaly results when the<br />

GH-producing tumor develops after puberty. Patients<br />

usually develop increased stature, with enlarged extremities<br />

manifested by increases in hat and (glove) sizes, prognathism,<br />

and visceromegaly. The serum levels of IGF1 is<br />

increased and may be more sensitive than increased serum<br />

GH in establishing the diagnosis [9, 35].<br />

Microscopic examination shows variable patterns<br />

depending on the cellular composition. Acidophilic cells<br />

are common (Fig. 2A), but chromophobic and amphophilic<br />

cells may also be present. Immunohistochemical<br />

staining is positive for GH, usually in a diffuse pattern<br />

(Fig. 2B). Other cell types such as PRL and/or immunoreactive<br />

alpha subunit cells may also be present in the<br />

tumors. Various subtypes of GH adenomas have been<br />

recognized, based largely on ultrastructural studies, which<br />

usually correlate with immunohistochemical findings.<br />

Densely Granulated GH Cell Adenomas<br />

These tumors correspond to the classical type of GH<br />

adenomas associated with acromegaly. These tumors are<br />

characterized by slow growth and limited invasion into<br />

tissues adjacent to the sella turcica. The tumors are<br />

strongly positive for GH, but may also be reactive for<br />

PRL, alpha subunit, and/or TSH. Ultrastructural<br />

examination shows dense, core granules measuring<br />

150–600 nm in diameter, with most secretory granules<br />

between 400 and 500 nm in diameter (Fig. 2C) [7, 9, 35].

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!